<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib0003">
 <element-citation publication-type="journal" id="sbref0003">
  <person-group person-group-type="author">
   <name>
    <surname>Eaton</surname>
    <given-names>J.W.</given-names>
   </name>
   <name>
    <surname>Menzies</surname>
    <given-names>N.A.</given-names>
   </name>
   <name>
    <surname>Stover</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Cambiano</surname>
    <given-names>V.</given-names>
   </name>
   <name>
    <surname>Chindelevitch</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Cori</surname>
    <given-names>A.</given-names>
   </name>
  </person-group>
  <article-title>Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: A combined analysis of 12 mathematical models</article-title>
  <source>The Lancet Global Health</source>
  <volume>2</volume>
  <issue>1</issue>
  <year>2014</year>
  <fpage>e23</fpage>
  <lpage>e34</lpage>
  <pub-id pub-id-type="doi">10.1016/s2214-109x(13)70172-4</pub-id>
  <pub-id pub-id-type="pmid">25104632</pub-id>
 </element-citation>
</ref>
